Beiersdorf and Rubedo Life Sciences have entered into a partnership. Multi-year strategic partnership We aim to develop innovative anti-aging solutions for the global face care market.German beauty giant further joins Rubedo strategic investorparticipated in a recently closed Series A funding round through Oscar & Paul Corporate Venture Capital Fund. Rubedo Life Science is a California-based biotechnology company with expertise in developing solutions targeting cellular aging.
Innovative anti-aging agent
The partnership revolves around the exploration of novel compounds derived from Rubedo’s extensive research program, specifically targeting cellular aging.
senescent cells [Latin senescere = to grow old, to age] As we age, it accumulates and causes inflammation, which can contribute to age-related skin changes and medical conditions. These compounds are sourced from Rubedo’s topical dermatology program and have senolytic and anti-inflammatory properties.
As part of this partnership, Beiersdorf will: in vitro and in silico We conduct research and rigorous evaluation of rubedo candidate compounds. This collaboration will result in in vivo studies in humans aimed at validating the effectiveness of selected substances in cosmetic skin care formulations.
“Our mission is to define the future of skin care through breakthrough innovation.” commented Beiersdorf CEO Vincent Warnery. “By partnering with Rubedo and combining the cutting-edge expertise of both parties, we aim to redefine the standard in anti-aging skin care.”
Dr. Gitta Neufang, Beiersdorf Corporate Senior Vice President Global R&D Added: “We believe that the highly dynamic research field of cellular aging has great potential to develop superior solutions for skin rejuvenation.”
“By combining Rubedo’s expertise in cellular aging with Beiersdorf’s expertise in skin care innovation, this partnership will revolutionize the skin care product landscape, creating new solutions to treat cellular aging for healthy, youthful-looking skin. may be provided to consumers.” concluded Marco Quarta, CEO of Rubedo Life Sciences.
Beiersdorf’s brand portfolio includes Nivea, Eucerin and La Prairie. [The company recently announced the development of a newly patented ingredient. Trademarked by Beiersdorf as Glycostop, the new NAHP [N-acetyl-L-hydroxyproline] Targets skin aging and wrinkle formation caused by sugar, known as glycation. ->https://www.premiumbeautynews.com/en/nivea-launches-q10-dual-action,23765]
